BDTX

Black Diamond Therapeutics Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth↑ 9/10
  • Momentum↓ 3/10
Black Diamond Therapeutics sales and earnings growth
BDTX Growth
Great
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 128.57%
  • FCF Y/Y↑ 134.98%
Black Diamond Therapeutics gross and profit margin trends
BDTX Profitability
Great
  • Gross margin ↑ 100.00%
  • EPS margin↑ 30.70%
  • ROIC↑ 20.30%
Black Diamond Therapeutics net debt vs free cash flow
BDTX Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Black Diamond Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗